Login to Your Account

American Society of Clinical Oncology

Cancer Vaccine Comeback: Data Boost Antigenics and Others

By Trista Morrison

Tuesday, June 2, 2009
Cancer vaccines are back in fashion, thanks to Dendreon Corp.'s recent Phase III success with Provenge (sipuleucel-T) in prostate cancer, and encouraging data presented this weekend at the American Society of Clinical Oncology's annual meeting sent shares of several other cancer vaccine players skyrocketing. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription